Literature DB >> 28469010

Insights into the Dual Role of Inflammation after Spinal Cord Injury.

Ruslan Rust1, Julia Kaiser2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28469010      PMCID： PMC6596496          DOI： 10.1523/JNEUROSCI.0498-17.2017

Source DB:  PubMed          Journal:  J Neurosci        ISSN： 0270-6474            Impact factor:   6.167


× No keyword cloud information.
  21 in total

1.  Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord.

Authors:  L Schnell; S Fearn; H Klassen; M E Schwab; V H Perry
Journal:  Eur J Neurosci       Date:  1999-10       Impact factor: 3.386

2.  IL-1 receptor antagonist prevents apoptosis and caspase-3 activation after spinal cord injury.

Authors:  O Nesic; G Y Xu; D McAdoo; K W High; C Hulsebosch; R Perez-Pol
Journal:  J Neurotrauma       Date:  2001-09       Impact factor: 5.269

Review 3.  Post-traumatic inflammation following spinal cord injury.

Authors:  O N Hausmann
Journal:  Spinal Cord       Date:  2003-07       Impact factor: 2.772

4.  Endothelial growth factors VEGF and bFGF differentially enhance monocyte and neutrophil recruitment to inflammation.

Authors:  Sandra I Zittermann; Andrew C Issekutz
Journal:  J Leukoc Biol       Date:  2006-07-03       Impact factor: 4.962

5.  TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.

Authors:  H A Arnett; J Mason; M Marino; K Suzuki; G K Matsushima; J P Ting
Journal:  Nat Neurosci       Date:  2001-11       Impact factor: 24.884

6.  The cellular inflammatory response in human spinal cords after injury.

Authors:  Jennifer C Fleming; Michael D Norenberg; David A Ramsay; Gregory A Dekaban; Alexander E Marcillo; Alvaro D Saenz; Melissa Pasquale-Styles; W Dalton Dietrich; Lynne C Weaver
Journal:  Brain       Date:  2006-10-28       Impact factor: 13.501

Review 7.  Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury.

Authors:  Gregory W J Hawryluk; James Rowland; Brian K Kwon; Michael G Fehlings
Journal:  Neurosurg Focus       Date:  2008       Impact factor: 4.047

8.  Elevated neuronal expression of CD200 protects Wlds mice from inflammation-mediated neurodegeneration.

Authors:  Tanuja Chitnis; Jaime Imitola; Yue Wang; Wassim Elyaman; Prianka Chawla; Maia Sharuk; Khadir Raddassi; Roderick T Bronson; Samia J Khoury
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

9.  TNF-alpha blockage in a mouse model of SCI: evidence for improved outcome.

Authors:  Tiziana Genovese; Emanuela Mazzon; Concetta Crisafulli; Rosanna Di Paola; Carmelo Muià; Emanuela Esposito; Placido Bramanti; Salvatore Cuzzocrea
Journal:  Shock       Date:  2008-01       Impact factor: 3.454

10.  Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions.

Authors:  Nathalie Koning; Dick F Swaab; Robert M Hoek; Inge Huitinga
Journal:  J Neuropathol Exp Neurol       Date:  2009-02       Impact factor: 3.685
View more
  26 in total

1.  Cellular Inflammatory Response of the Spleen After Acute Spinal Cord Injury in Rat.

Authors:  Feng Wu; Xiao-Yan Ding; Xiao-Hui Li; Min-Jie Gong; Jia-Qi An; Jiang-Hua Lai; Sheng-Li Huang
Journal:  Inflammation       Date:  2019-10       Impact factor: 4.092

Review 2.  Mechanism of Neuroprotection Against Experimental Spinal Cord Injury by Riluzole or Methylprednisolone.

Authors:  Cynthia Sámano; Andrea Nistri
Journal:  Neurochem Res       Date:  2017-12-30       Impact factor: 3.996

3.  Effect of Acute Physical Interventions on Pathophysiology and Recovery After Spinal Cord Injury: A Comprehensive Review of the Literature.

Authors:  Nicholle E Lewis; Troy Q Tabarestani; Brianna R Cellini; Nina Zhang; Eric J Marrotte; Haichen Wang; Daniel T Laskowitz; Muhammad M Abd-El-Barr; Timothy D Faw
Journal:  Neurospine       Date:  2022-09-30

4.  Perlecan Improves Blood Spinal Cord Barrier Repair Through the Integrin β1/ROCK/MLC Pathway After Spinal Cord Injury.

Authors:  Changnan Xie; Yihan Wang; Jinfeng Wang; Yizhou Xu; Haining Liu; Jiasong Guo; Lixin Zhu
Journal:  Mol Neurobiol       Date:  2022-10-10       Impact factor: 5.682

Review 5.  Mesenchymal Stem Cell-Macrophage Choreography Supporting Spinal Cord Repair.

Authors:  Inés Maldonado-Lasunción; Joost Verhaagen; Martin Oudega
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

6.  Implantation of Engineered Axon Tracts to Bridge Spinal Cord Injury Beyond the Glial Scar in Rats.

Authors:  Patricia Zadnik Sullivan; Ahmed AlBayar; Justin C Burrell; Kevin D Browne; John Arena; Victoria Johnson; Douglas H Smith; D Kacy Cullen; Ali K Ozturk
Journal:  Tissue Eng Part A       Date:  2021-03-08       Impact factor: 4.080

7.  TRPV4: A trigger of pathological RhoA activation in neurological disease.

Authors:  Anna M Bagnell; Charlotte J Sumner; Brett A McCray
Journal:  Bioessays       Date:  2022-03-17       Impact factor: 4.653

8.  Apolipoprotein E Deficiency Exacerbates Spinal Cord Injury in Mice: Inflammatory Response and Oxidative Stress Mediated by NF-κB Signaling Pathway.

Authors:  Xuan Yang; Shurui Chen; Zhenya Shao; Yuanlong Li; He Wu; Xian Li; Liang Mao; Zipeng Zhou; Liangjie Bai; Xifan Mei; Chang Liu
Journal:  Front Cell Neurosci       Date:  2018-05-23       Impact factor: 5.505

9.  Perturbing chondroitin sulfate proteoglycan signaling through LAR and PTPσ receptors promotes a beneficial inflammatory response following spinal cord injury.

Authors:  Scott Dyck; Hardeep Kataria; Arsalan Alizadeh; Kallivalappil T Santhosh; Bradley Lang; Jerry Silver; Soheila Karimi-Abdolrezaee
Journal:  J Neuroinflammation       Date:  2018-03-20       Impact factor: 8.322

10.  A Single Dose of Atorvastatin Applied Acutely after Spinal Cord Injury Suppresses Inflammation, Apoptosis, and Promotes Axon Outgrowth, Which Might Be Essential for Favorable Functional Outcome.

Authors:  Katarina Bimbova; Maria Bacova; Alexandra Kisucka; Jaroslav Pavel; Jan Galik; Peter Zavacky; Martin Marsala; Andrea Stropkovska; Jana Fedorova; Stefania Papcunova; Jana Jachova; Nadezda Lukacova
Journal:  Int J Mol Sci       Date:  2018-04-07       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.